J. P. Thomas

STEREOSPECIFICITY IN A NEW TYPE OF SYNTHETIC ANTITUBERCULOUS AGENT1,2

R. Shepherd, C. Baughn, R. G. Wilkinson, 1961 .

STRUCTURE‐ACTIVITY STUDIES LEADING TO ETHAMBUTOL, A NEW TYPE OF ANTITUBERCULOUS COMPOUND *

R. Shepherd, C. Baughn, R. G. Wilkinson, 1966, Annals of the New York Academy of Sciences.

Water-Soluble Third Generation Antitumor Platinum Complexes, (2,2-Bis-(aminomethyl)-1,3-propanediol-N,N′)(1,1-cyclobutanedicarboxylato(2-)-O,O′)platinum(II) and (1,1-Cyclobutanedicarboxylato(2-)-O,O′)(tetrahydro-4H-pyran-4,4-dimethana

S. Lang, Yang-i Lin, R. Haltiwanger, 1990 .

A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol).

R. Shepherd, C. Baughn, R. G. Wilkinson, 2015, The American review of respiratory disease.

Clinical pharmacology of ethambutol.

V. Place, J. P. Thomas, 1963, The American review of respiratory disease.

Ethambutol dose-plasma level correlation studies in guinea pigs.

F. Durr, J. P. Thomas, 1983, The American review of respiratory disease.

A new family of water-soluble, third generation antitumor platinum complexes.

S. Lang, R. Wallace, F. Durr, 1989, Journal of medicinal chemistry.